Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Brian Joseph Kieser is Interim CEO at Nexgel. OQRO lists 12 transactions filed with the SEC under this name, the latest on Nov 14, 2026, each linked to the official Form 4.
Interim CEO
Disclosures on record
12
Companies involved
1
NexgelNXGL
12 disclosures · May 2026 – Nov 2026 · 1 bought
Nov 10, 2026Bought~$733Kdisclosed Nov 14
DetailsOfficial recordNov 10, 202683Kdisclosed Nov 14
DetailsOfficial recordNov 10, 2026182Kdisclosed Nov 14
DetailsOfficial recordNov 10, 202642Kdisclosed Nov 14
DetailsOfficial recordNov 10, 202642Kdisclosed Nov 14
DetailsOfficial recordNov 10, 2026458Kdisclosed Nov 14
DetailsOfficial recordNov 10, 20261Mdisclosed Nov 14
DetailsOfficial recordNov 10, 2026229Kdisclosed Nov 14
DetailsOfficial recordNov 10, 2026229Kdisclosed Nov 14
DetailsOfficial recordNov 10, 2026133Kdisclosed Nov 14
DetailsOfficial recordMay 11, 20261.67Mdisclosed May 18
DetailsOfficial recordMay 11, 2026833Kdisclosed May 18
DetailsOfficial recordBrian Joseph Kieser bought shares on the open market in 2026.
Brian Joseph Kieser reported 1 open-market purchase and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $733K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , Brian Joseph Kieser reported holding 133,216 shares of Nexgel (NXGL), worth about $517K at the last close of $4 (Nov 13, 2026), held through a sequence lifescience, inc. In the last 12 months, Brian Joseph Kieser bought $733K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Nexgel NXGL | 133,216 | 133K sequence lifescience, inc | $4 | $517K | Nov 10, 2026 |
Is this Brian Joseph Kieser’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 10, 2026, Brian Joseph Kieser reported holding 133,216 shares of Nexgel (NXGL), held indirectly. At the last close of $4 on Nov 13, 2026, that is about $517K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Brian Joseph Kieser reported 1 open-market purchase worth $733K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Brian Joseph Kieser bought shares on the open market in 2026.
In SEC filings since 2026: the latest open-market purchase is from 2026; no open-market sale is on record.
Nexgel (NXGL), from 2026 to 2026: 1 purchase and 0 sales.
Brian Joseph Kieser reported 1 open-market purchase and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.